LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 92.25 | 27.76 | 276 | 6873 | 0.0402 | 0.3349 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 92.25 | 27.76 | 7321 | 6873 | 1.0651 | 1.0159 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 92.25 | 27.76 | 692 | 6873 | 0.1007 | 0.4985 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 92.25 | 27.76 | 6566 | 6873 | 0.9553 | 0.9885 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 93.96 | 27.76 | 240 | 6849 | 0.0350 | 0.3119 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 93.96 | 27.76 | 7440 | 6849 | 1.0863 | 1.0209 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 93.96 | 27.76 | 510 | 6849 | 0.0745 | 0.4424 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 93.96 | 27.76 | 6654 | 6849 | 0.9715 | 0.9927 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 95.66 | 27.76 | 264 | 6712 | 0.0393 | 0.3291 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 95.66 | 27.76 | 7552 | 6712 | 1.1250 | 1.0300 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 95.66 | 27.76 | 333 | 6712 | 0.0496 | 0.3686 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 95.66 | 27.76 | 6724 | 6712 | 1.0017 | 1.0004 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 1.95 | 27.76 | 355 | 225 | 1.5768 | 1.3255 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 1.95 | 27.76 | 4 | 225 | 0.0178 | -0.4735 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 1.95 | 27.76 | 584 | 225 | 2.5939 | 1.7423 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.66 | 27.76 | 467 | 283 | 1.6448 | 1.3198 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.66 | 27.76 | 7 | 283 | 0.0247 | -0.3368 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.66 | 27.76 | 630 | 283 | 2.2189 | 1.5364 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.36 | 27.76 | 567 | 320 | 1.7699 | 1.3512 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.36 | 27.76 | 9 | 320 | 0.0281 | -0.2733 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.36 | 27.76 | 708 | 320 | 2.2100 | 1.5040 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | D10 |